Acceptance and Commitment Therapy (ACT) Tele-Counselling

NCT ID: NCT05385458

Last Updated: 2023-05-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-05-30

Study Completion Date

2023-03-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A randomized 2-group controlled trial will be conducted to explore the potential effect and potential feasibility of a new Acceptance and Commitment Therapy (ACT) tele-counselling program to improve mental health services for family caregivers of persons with dementia in the province of New Brunswick in Canada. The ACT tele-counselling program was launched in January 2021 with the aim of improving access to high quality psychotherapy for family caregivers, particularly in rural areas. A target sample size of 80 participants will be recruited and randomly allocated to either the ACT program or to usual care services. Mixed methods (QUANTITATIVE + qualitative) will be used to evaluate the potential impact of the ACT program compared to usual care on participant's mental health, and to generate recommendations for the expansion and continuation of the program outside of the province.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Family caregivers of persons with dementia have limited access to high quality psychotherapy in NB and across Canada, despite experiencing high levels of burden, depression, anxiety and social isolation. This feasibility pilot study will use a randomized two-group controlled trial design to evaluate the feasibility, acceptability and potential effect of a new Acceptance and Commitment Therapy (ACT) tele-counselling program offered by the Alzheimer Society of NB to family/friend caregivers. The program was launched in February 2021 and requires evaluation to maintain funding and inform implementation practices (i.e., scale-up) into other provinces.

Approximately 80 French/English-speaking adult caregivers of persons living with dementia will be recruited to participate in the study. We anticipate an attrition rate of approximately 25% and aim to retain a sample of 60 (30 participants per group). Participants will be screened for eligibility and those who demonstrate severe anxiety, depression or stress in 2 or more subscales according to the DASS-21 questionnaire will not be eligible to participate in the study and will be enrolled directly to the ACT program at the Alzheimer Society of NB. Eligible participants will be randomly assigned to either a usual care or intervention group.

Usual Care Group: Participants will receive usual care services at the Alzheimer Society including: First Link check-in telephone call once at the beginning of the study and a 2nd phone call 3 months later from an Alzheimer Society staff member. They would also have access to monthly support groups and education classes as they wish. Use of services will be tracked as per usual by the Alzheimer Society over 12 weeks.

Intervention Group: Participants will attend 6-8 individual tele-counselling sessions over 12-24 weeks with the psychotherapist who developed the ACT program at the Alzheimer Society. Sessions will last 45-60 minutes and be delivered in French or English via text, Zoom or telephone using Health Insurance Portability and Accountability Act (HIPAA) compliant technology. Participants will select their preferred mode of delivery for the program. Sessions will include ACT methods such as: identifying presenting concerns, making contact with the present moment, identifying values, accepting the situation and setting boundaries/expectations, and examining thoughts. All sessions will be recorded and 20% randomly selected to be reviewed by a research team member to evaluate intervention fidelity. Participants can refuse to have their session recorded and remain in the study. Participants in the Intervention Group will also have access to Usual Care services.

Participants will complete a pre-post test with outcome measures completed at baseline (T1) and after attending either Usual Care or the ACT program (T2) to assess potential effect. Participants will complete electronic or paper questionnaires (administered and returned via postal mail). Questionnaires have evidence for reliability and validity in French and English and have been used to evaluate ACT effectiveness in family caregivers. Outcome measures will include: Depression, Anxiety and Stress Scale (DASS-21), Acceptance and Action Questionnaire II (AAQ-11), Zarit Caregiver Burden-6 (ZBI-6), and the Engagement in Meaningful Activities Survey (EMAS).

Feasibility and acceptability of the intervention will be evaluated by tracking participant movement (i.e., recruitment, retention, sessions completed). Participants in the Intervention Group will also complete the System Usability Scale (SUS) and the Client Satisfaction Questionnaire (CSQ-8) after completing the Intervention. Telephone or computer interviews lasting 1 hour will be conducted with 10 participants in the Intervention Group to explore perceptions of the intervention, facilitators and barriers. 1 computer or telephone focus group will be conducted with 5-6 staff members of the Alzheimer Society involved in delivery of the program to explore perceptions and recommendations for program implementation and scale-up. Interviews and the focus group will be audio recorded and transcribed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acceptance and Commitment Therapy Caregiver Burden Digital Health Technology Mental Health Psychotherapy Counselling Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two group randomized controlled trial
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
One investigator who will have no contact with participants will generate a randomization sequence. The research assistant who enrols participants in the studies will be blinded to the randomization sequence. They will contact the investigator to be told what group the participant is allocated. It is not possible to mask participants. Investigators will be blinded to groups when assessing and comparing outcomes.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ACT Intervention

Participants will attend 6-8 individual psychotherapy sessions via telephone, text or videoconference. Sessions will last approximately 1 hour and occur every 3-4 weeks. Participants will be enrolled in the Intervention Group for 18-36 weeks. All sessions will be audio recorded. Participants will also be able to attend all available usual care services such as: support groups, First Link, education classes at the Alzheimer Society. Any services utilized will be documented by Alzheimer Society staff.

Group Type EXPERIMENTAL

ACT Intervention

Intervention Type BEHAVIORAL

Acceptance and Commitment Therapy

Usual Care

Participants will be enrolled as an Alzheimer Society client. Participants will receive 1 First Link 'check-in' telephone call from a staff member at the time of enrolment. Participants will receive a 2nd 'check-in' First Link telephone call from a staff member 3-4 months following enrolment. Participants will be enrolled in the Usual Care Group 12-16 weeks. Participants will also be able to attend all available usual care services such as: support groups, etc. Any services utilized will be documented by Alzheimer Society staff.

Group Type ACTIVE_COMPARATOR

Usual Care

Intervention Type OTHER

Usual Care Services

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACT Intervention

Acceptance and Commitment Therapy

Intervention Type BEHAVIORAL

Usual Care

Usual Care Services

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult over 19 years old residing in New Brunswick, Canada
* Able to speak and read English or French
* Unpaid, informal caregiver to a person living with dementia (no diagnosis required)
* High level on 2 subscales or less on the Depression, Anxiety and Stress Scale
* Current or previous use of any mental health services

Exclusion Criteria

* Less than 19 years old or not residing in New Brunswick, Canada
* Unable to speak and read English or French
* Not an unpaid informal caregiver to a person living with dementia
* High level on more than 2 subscales on the Depression, Anxiety and Stress Scale
* Acute mental health disorder such as: schizophrenia or bipolar disorder
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alzheimer Society of New Brunswick

UNKNOWN

Sponsor Role collaborator

Mount Allison University

UNKNOWN

Sponsor Role collaborator

University of Ottawa

OTHER

Sponsor Role collaborator

McMaster University

OTHER

Sponsor Role collaborator

McGill University

OTHER

Sponsor Role collaborator

University of New Brunswick

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Pamela Durepos

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pamela Durepos, PhD

Role: PRINCIPAL_INVESTIGATOR

University of New Brunswick

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Alzheimer Society of New Brunswick

Fredericton, New Brunswick, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Durepos P, Ricketts N, Olthuis JV, Gould ON, Boamah SA, McCloskey R, Lanteigne M, Giberson ER, Caverhill K, Pickford K, MacBean C, Kaasalainen S. Acceptance and Commitment Therapy Tele-Counselling Program With Care Partners of Persons Living With Dementia: A Pilot Feasibility RCT. J Appl Gerontol. 2025 May 12:7334648251338303. doi: 10.1177/07334648251338303. Online ahead of print.

Reference Type DERIVED
PMID: 40353485 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MHRC-NBHRF Mental Health

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ACT for Individuals With MNCD and Their Care Partners
NCT07239609 NOT_YET_RECRUITING PHASE1